Montefiore Medical Center, Bronx, NY. RATIONALE: Digital health interventions play a key role in improving outcomes among asthma patients. We reviewed the literature to evaluate these interventions' impact on patient-reported outcomes (PROs). METHODS: We searched PubMed and ClinicalTrials.gov to identify studies (January 2001-June 2018) regarding information technology (IT)-based interventions and with endpoints including PROs. We descriptively analyzed the search results. RESULTS: We identified 25 studies on ClinicalTrials.gov and 22 on PubMed; among these, 16 (34.0%) focused on adults, 15 (31.9%) on pediatrics, 9 (19.2%) with patients of all ages, and 7 (14.9%) did not specify age. IT-based interventions included Internet-based self-report tools and electronic PRO questionnaires (n514, 29.8%), smartphone and tabletbased apps (n512, 25.5%), mobile electronic adherence sensors (n55, 10.6%), electronic asthma diaries (n55, 10.6%), multimedia educational interventions (n54, 8.5%), mobile telehealth visits (n53, 6.4%); four studies (8.5%) assessed more than one IT-based intervention. Studies collected asthma PRO measures including asthma control and self-management skills (n522, 46.8%), treatment self-efficacy (n57, 14.9%), dyspnea severity/symptoms/functional limitations (n54, 8.5%), quality of life (n51, 2.1%), and lung clearance index (n51, 2.1%). Twelve studies (25.5%) assessed more than one asthma PRO. Study interventions impacted the PROs as follows: improved (n518, 38.3%), no difference (n54, 8.5%), and not improved (n54, 8.5%). Twenty-one studies (44.7%), especially on ClinicalTrials.gov, have yet to release the interventions' impact on the outcomes. CONCLUSIONS: Several IT-based health interventions have shown promise in favorably impacting PROs for asthma patients. Further studies need to prospectively evaluate these findings on a larger scale.
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